Extracellular High-Mobility Group Box 1 is Increased in Patients with Behçet’s Disease with Intestinal Involvement

다국어 초록 (Multilingual Abstract)

High-mobility group box 1 (HMGB1) protein has been demonstrated to play an important role in chronic inflammatory diseases including rheumatoid arthritis, and systemic lupus erythematosus. This study investigated the association between extracellular HMGB1expression and disease activity, and clinical features of Behçet’s disease (BD). Extracellular HMGB1 expression in the sera of 42 BD patients was measured and was compared to that of 22 age- and sex-matched healthy controls. HMGB1 expression was significantly increased in BD patients compared to healthy controls (78.70 ± 20.22 vs 10.79 ± 1.90 ng/mL, P = 0.002). In addition, HMGB1 expression was significantly elevated in BD patients with intestinal involvement compared to those without (179.61 ± 67.95 vs 61.89 ± 19.81ng/mL, P = 0.04). No significant association was observed between HMGB1 concentration and other clinical manifestations, or disease activity. It is suggested that extracellular HMGB1 may play an important role in the pathogenesis of BD.

참고문헌 (Reference)

1 Andersson U, "The role of HMGB1 in the pathogenesis of rheumatic disease" 1799 : 141-148, 2010

2 Chavakis T, "The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment" 198 : 1507-1515, 2003

3 이승우, "The Prevalence and Clinical Characteristics of Esophageal Involvement in Patients with Behçet’s Disease: A Single Center Experience in Korea" 대한의학회 24 (24): 52-56, 2009

4 Turkoz Y, "Serum levels of soluble P-selectin are increased and associated with disease activity in patients with Behçet’s syndrome" 2005 : 237-241, 2005

5 Zouboulis CC, "Pathogenesis of Adamantiades-Behçet’s disease" 528 : 161-171, 2003

6 Pisetsky DS, "High-mobility group box protein 1 (HMGB1): an alarmin mediating the pathogenesis of rheumatic disease" 10 : 209-, 2008

7 Lotze MT, "High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal" 5 : 331-342, 2005

8 Kokkola R, "High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis" 46 : 2598-2603, 2002

9 Taniguchi N, "High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine" 48 : 971-981, 2003

10 Andersson U, "High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes" 192 : 565-570, 2000

11 Abdulahad DA, "HMGB1 in systemic lupus Erythematosus: its role in cutaneous lesions development" 9 : 661-665, 2010

12 Sappington PL, "HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice" 123 : 790-802, 2002

13 Jiang W, "Expression of high mobility group protein 1 in the sera of patients and mice with systemic lupus erythematosus" 67 : 727-728, 2008

14 Jung YS, "Expression of a Soluble Triggering Receptor Expressed on Myeloid Cells-1(sTREM-1P)Correlates with Clinical Disease Activity in Intestinal Behcet's Disease" JOHN WILEY & SONS INC 17 (17): 2130-2137, 2011

15 Ulfgren AK, "Down-regulation of the aberrant expression of the inflammation mediator high mobility group box chromosomal protein 1 in muscle tissue of patients with polymyositis and dermatomyositis treated with corticosteroids" 50 : 1586-1594, 2004

16 International Study Group for Behçet’s Disease, "Criteria for diagnosis of Behçet’s disease. International Study Group for Behçet’s Disease" 335 : 1078-1080, 1990

17 Yazici H, "Behçet’s syndrome: disease manifestations, management, and advances in treatment" 3 : 148-155, 2007

18 Direskeneli H, "Behçet’s disease: infectious aetiology, new autoantigens, and HLA-B51" 60 : 996-1002, 2001

19 Sakane T, "Behçet’s disease" 341 : 1284-1291, 1999

20 Park JS, "Activation of gene expression in human neutrophils by high mobility group box 1 protein" 284 : 870-879, 2003